Dr. Eva Maria Rzucidlo, MD

Dr. Rzucidlo practices at McLeod Vascular Associates Seacoast in Little River, South Carolina.

Dr. Rzucidlo's NPI, 1699787523, was assigned on August 12, 2006. Dr. Rzucidlo holds South Carolina license 38867.

Dr. Rzucidlo's primary practice is McLeod Vascular Associates Seacoast, at 3980 E Hwy 9, Little River, SC 29566 in Horry County. The practice phone is (843) 366-3755.

Dr. Rzucidlo's primary practice is McLeod Vascular Associates Seacoast in Little River, South Carolina. Dr. Rzucidlo is also affiliated with McLeod Health Loris. The medical group on file is McLeod Physician Associates. Dmand AI also links Dr. Rzucidlo to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rzucidlo practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Rzucidlo's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Rzucidlo's licenses on file in 2 states: South Carolina and New Hampshire.

CMS data shows 2,136 Medicare services from Dr. Rzucidlo across 15 procedure codes in 2024, for 1,302 Medicare patients. Medicare paid $227,993 for them.

CMS counts 1,302 Medicare patients who saw Dr. Rzucidlo in 2024. The largest group is 75 to 84, with 609 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rzucidlo's median patient age at 74, with 45% women.

In 2024, Dr. Rzucidlo wrote 318 Medicare Part D claims for 135 patients. 95% of them were for generic drugs. CMS names the drug for 256 of them, across 4 drugs with 11 or more claims each, at $4,117 in total drug cost. In 2023, CMS named 276 claims across 6 drugs.

Dr. Rzucidlo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of leg revascularization (restoring blood flow) by Dr. Rzucidlo, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Rzucidlo, published from 2011 to 2021. 2011 was the busiest year, with 5. The most frequent topics are Blood Vessel Prosthesis Implantation, Muscle, Smooth, Vascular and Myocytes, Smooth Muscle. Dr. Rzucidlo has published most often in J Vasc Surg. Dr. Rzucidlo's most frequent co-authors are Philip Paul Goodney, MD, David H. Stone, MD and Daniel Bernard Walsh, MD.

CMS Open Payments shows 159 general payments to Dr. Rzucidlo from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Silk Road Medical, Inc. paid the most, $1,229.